Granules Life Sciences receives USFDA approval for new Hyderabad facility to manufacture diabetes drug Metformin HCL. Capacity: 10 billion tablets annually. Read more about this pharmaceutical milestone.
Ajai Chowdhry, HCL Technologies co-founder, warns that advanced technologies are being weaponized in international trade wars. Discover why India needs urgent strategic response to protect its technological sovereignty and economic future.
Ajai Chowdhary warns of critical security threats from imported Chinese semiconductors and calls for immediate government action to protect national data.
Bessemer Venture Partners reveals why Indian IT majors are losing the AI race and how nimble startups are poised to dominate the $5 trillion AI opportunity in India.
Groundbreaking research reveals two existing medications - diabetes drug metformin and liver disease treatment ursodeoxycholic acid - could significantly enhance brain function and protect against cognitive decline.
Noida Authority transforms Sector 126 with a 500-meter model road featuring smart infrastructure, green spaces, and vendor zones. HCL office connectivity enhanced.
Indian markets poised for optimistic opening as GIFT Nifty trends upward. Infosys, HCL Tech, Maruti, and Power Grid in focus amid falling gold prices and mixed global signals. Get expert analysis on today's trading strategy.
Discover how India's top 5 IT services companies are investing billions in generative AI, reshaping their business models, and competing for $6-8 billion in new contracts as artificial intelligence transforms the industry.
Exclusive analysis of India's top 4 IT stocks after Q2 FY2025 results. Discover which company delivered the strongest performance and which stock analysts are betting on for maximum returns.